Compare Trane Technologies plc (TT) vs State Street SPDR S&P Biotech ETF (XBI) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Trane Technologies plc vs State Street SPDR S&P Biotech ETF — how do they compare? Trane Technologies plc trades at $471.29 (market cap $105.17B), while State Street SPDR S&P Biotech ETF trades at $147.06 (market cap $10.27B). The key difference: Trane Technologies plc is far larger — about 10.2× State Street SPDR S&P Biotech ETF's market cap, and Trane Technologies plc pays a 0.88% dividend while State Street SPDR S&P Biotech ETF pays none. Which is the better fit depends on your goals.
| TT | XBI | |
|---|---|---|
Market Cap | $105.17B | $10.27B |
Volume | 1,040,183 | 9,751,587 |
Sector | Industrials | Broad Market / Factor |
52-Week High | $503.46 | $169.55 |
52-Week Low | $376.43 | $107.32 |
Enterprise Value | $108.47B | — |
Dividend Yield | 0.88% | — |
Typical Hold Time | — | 39 Days |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
XBI trades at $146.8, down 3.04% today, with a bearish technical signal driven by selling pressure in moving averages. The ETF's modified equal-weight structure provides exposure to over 150 biotech companies, benefiting from M&A activity and positive clinical catalysts. Recent news highlights sector optimism from cancer vaccine breakthroughs and improved capital access, though the ETF carries higher volatility than diversified healthcare funds.
Outlook remains mixed with neutral analyst consensus but positive sector catalysts. Opportunities include biotech innovation and M&A potential, while risks involve high volatility, regulatory uncertainty, and expense ratios above broader healthcare ETFs. Investors should weigh targeted biotech exposure against sector-wide stability.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Trane Technologies plc
Trane Technologies plc is a global climate solutions company that designs, manufactures, and services heating, ventilation, and air conditioning (HVAC) and transport refrigeration equipment under its Trane and Thermo King brands.
Read more on TT →About State Street SPDR S&P Biotech ETF
XBI is an equal-weighted ETF that tracks the U.S. biotechnology segment. It provides diversified exposure to small, mid, and large-cap biotech firms involved in drug discovery and medical research, such as Moderna and Exact Sciences.
Read more on XBI →
